TABOURET Emeline
Primary tabs
Publications
http://api.archives-ouvertes.fr/search/?&fq=authLastNameFirstName_s:%28%22Tabouret+Emeline%22%29&fl=title_s,en_title_s,docid,label_s,en_label_s,authIdHal_s,halId_s,structId_i,uri_s,keyword_s,en_keyword_s,authLastNameFirstName_s,journalTitle_s,abstract_s,en_abstract_s,producedDate_tdate,producedDateY_i,language_s&sort=publicationDate_s+desc
-
Tailoring glioblastoma treatment based on longitudinal analysis of post-surgical tumor microenvironmentJournal of experimental & clinical cancer research2024
-
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 OligodendrogliomaJournal of Clinical Oncology2024
-
SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironmentCell Death and Disease2024
-
Brain tumoroids: Treatment prediction and drug development for brain tumors with fast, reproducible, and easy-to-use personalized modelsNeuro-Oncology2024
-
Radioligand therapies in meningioma – evidence and future directionsNeuro-Oncology2024
-
Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysisJournal of Neuro-Oncology2024
-
Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysisJournal of Neuro-Oncology2024
-
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomasNeuro-Oncology2024
-
Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.Journal of the Neurological Sciences2024
-
Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.Journal of the Neurological Sciences2024
-
Systemic and local immune responses to glioblastoma surgery help tailoring combinatory regimens2024
-
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA NetworkNeuro-Oncology Advances2024
-
Meningioma: International Consortium on Meningiomas (ICOM) consensus review on scientific advances & treatment paradigms for clinicians, researchers, and patientsNeuro-Oncology2024
-
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergismsEBioMedicine2023
-
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergismsEBioMedicine2023
-
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)European Journal of Cancer2023
-
TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal CarcinomaInternational Journal of Molecular Sciences2023
-
Deciphering the Action of Neuraminidase in Glioblastoma ModelsInternational Journal of Molecular Sciences2023
-
Radio-chemotherapy feasibility for biopsy-only unresectable IDH wild-type glioblastomas (BO-GBM)Neuro-Oncology Practice2023
-
SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination eraLeukemia & lymphoma2023
-
Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR StatusCancers2023
-
Challenges in glioblastoma research: focus on the tumor microenvironmentTrends in Cancer2023
-
Editorial: Novel diagnostic and therapeutic strategies in the management of cerebral gliomasFrontiers in Oncology2023
-
SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination eraLeukemia & lymphoma2023
-
Primary central nervous system lymphoma (PCNSL) in older patientsCurrent Opinion in Oncology2023
-
Innovative treatments for meningiomasRevue Neurologique2023
-
Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastomaActa Neuropathologica Communications2022
-
Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH-Mutant Gliomas: A French POLA Network StudyCancers2022
-
Prognostic value of circulating lymphocyte subsets in primary central nervous system lymphomaJournal of Neuro-Oncology2022
-
Diagnosis and Treatment of Pineal Region Tumors in Adults: A EURACAN OverviewCancers2022
